What is White Bagging?
White bagging refers to the distribution of specialty medication from a specialty pharmacy or PBM directly to the physician’s office, hospital, or clinic for administration to a specific patient.
White bagging is often used by oncology practices and other providers to obtain costly injectable or infusible medications that aren’t available in traditional pharmacies and must be administered by a health care provider.
Providers argue that white bagging can:
- Disrupt treatment schedules
- Reduce their ability to manage inventory
- Increase risk of delays
- Complicate patient care workflows
- Limit providers’ ability to use their own 340B or in-house pharmacy channels
Operational and Financial Challenges
A major challenge for health systems dealing with white bagging is the complexity it introduces for both operations and finances. Since medications are shipped from an external specialty pharmacy directly to the clinic for a specific patient, clinics must manage the storage of individualized medications—sometimes for many patients at once. This can create inventory headaches, especially if a patient’s treatment plan changes at the last minute, potentially leading to medication waste. Additionally, coordinating with outside pharmacies to ensure that medications arrive on time adds an extra layer of logistics, raising the risk of treatment delays.
Care Coordination Complications
White bagging also shifts some care coordination responsibilities onto the provider. The care team needs to be diligent about ensuring medications are tracked, stored properly, and ready when the patient arrives. Because these drugs are not part of the clinic’s regular inventory, there is less flexibility for same-day dose adjustments, and any hiccups in the supply chain can disrupt patient care.
Why do payers use white bagging?
Payers often use white bagging to control costs, route dispensing through preferred specialty pharmacies, reduce drug waste, and maintain tighter utilization management.
Why do providers often oppose white bagging?
Providers argue that white bagging can:
- Disrupt treatment schedules
- Reduce their ability to manage inventory
- Increase risk of delays
- Complicate patient care workflows
- Limit providers’ ability to use their own 340B or in-house pharmacy channels
What are the potential impacts of bagging practices on medication waste and treatment delays?
When it comes to bagging practices—especially white bagging—there are notable challenges related to medication waste and timing of patient care. Since medications are shipped directly from an external specialty pharmacy to a provider’s office or clinic for individual patients, clinics are tasked with storing these drugs until the patient’s appointment. This system can create headaches if treatment plans change at the last minute, as pre-allocated medication may no longer align with the patient’s new regimen, resulting in unnecessary waste.
Additionally, white bagging often requires clinics to juggle coordination across separate organizations. Providers need to ensure that the medication arrives in time for a scheduled appointment, but shipping delays or miscommunications can lead to missed treatment windows or rescheduling, disrupting patient care and lengthening the time to therapy.
In contrast, clear bagging—which relies on the health system’s own specialty pharmacy—typically allows for tighter control, reducing the risk of missed deliveries or excess inventory. Because the process remains internal, there’s more transparency, less opportunity for communication breakdowns, and generally a smoother workflow, all of which help prevent wasted medication and minimize treatment delays.
What is a white bagging pharmacy?
A white bagging pharmacy is typically a specialty pharmacy outside of a health system and is seen by providers as more inflexible than the traditional system that distributes medication directly to a physician’s office, hospital, or clinic for administration.
Why might health system specialty pharmacies prefer “clear bagging”?
Health system specialty pharmacies often lean toward “clear bagging” because it keeps the entire medication process within their own network, offering greater transparency and control at each step. When using clear bagging, the pharmacy—provided it has both payer and manufacturer access—can dispense drugs from its own system pharmacy. This means all coordination, from dispensing to delivery at the clinic, happens internally.
There are several reasons this approach is preferred:
- Improved Coordination: Internal handling streamlines processes, reducing potential treatment delays caused by working with outside pharmacies.
- Financial Control: The health system can handle billing directly, which allows it to keep financial accountability and potential revenues in-house.
- Enhanced Transparency: Keeping all touchpoints internal makes it easier to track medications, maintain inventory accuracy, and ensure the right drugs get to the right patients.
- Fewer Barriers: Clear bagging avoids the disruptions and complications that can arise from external specialty pharmacies and allows for smoother communication across teams.
Overall, these advantages mean health system specialty pharmacies can operate more efficiently and provide a more reliable experience for both providers and patients.
How do bagging practices differ from “buy and bill?”
The main distinction between “buy and bill” and the various bagging practices—white, brown, clear, and gold—boils down to how medications are sourced, billed, and delivered to patients.
With the traditional buy and bill method, the provider purchases and stores medication on-site. After the medication is administered, the provider bills the medical benefit, and the patient typically sees any related charges on their medical bill after treatment.
Bagging practices shake up this routine:
- Bagging (whether white, brown, clear, or gold) means the medication is dispensed by a pharmacy—often a specialty pharmacy—and usually billed under the pharmacy benefit rather than the medical benefit.
- The pharmacy holds the medication until it is dispensed for a specific patient, then ships it directly to the provider (white bagging), to the patient for them to bring in (brown bagging), or follows other protocols (clear and gold bagging).
- Patients may need to pay their copay at the pharmacy before getting their treatment, in contrast to receiving a bill post-visit.
This shift affects more than finances; it changes how providers manage their inventory and care schedules. When hospitals or clinics lose control over procuring medications, they can face increased administrative work, disruptions in their supply chain, and even potential treatment delays. On the other hand, maintaining an in-house medication inventory (as with buy and bill) allows for more flexibility, helps prevent waste, and streamlines the patient experience.
What are the differences in insurance billing and financial operations between bagging practices and buy and bill?
The key distinction between bagging practices (white, brown, clear, and gold bagging) and traditional buy and bill comes down to how the medication is paid for and who manages the inventory:
- Buy and Bill: In this approach, the healthcare provider purchases medications upfront, stores them on-site, and bills the patient’s medical benefit after administering the drug. The billing and reimbursement occur after treatment, creating more flexibility for providers to manage their inventory, respond to dosing changes, and coordinate care without waiting for outside shipments.
- Bagging Practices: Here, medications are billed through the patient’s pharmacy benefit, not the medical benefit. The drug is dispensed by a specialty pharmacy and shipped to the provider or, in some cases, directly to the patient for administration. The patient is typically responsible for a copay or cost-sharing amount before treatment is given. Since the medication isn’t part of the clinic’s in-house inventory, providers have less control over timing and may face more administrative work coordinating deliveries and verifying insurance approvals.
Operational and Financial Impact:
- Inventory Control: Buy and bill allows providers to directly manage drug inventory, ensuring supply chain integrity and reducing the risk of delays. Bagging can complicate inventory processes since the medication arrives for a specific appointment and isn’t kept on hand.
- Payment Timing: With buy and bill, patients are usually billed after receiving care. With bagging, patients may pay a copay prior to treatment.
- Administrative Burden: Buy and bill centralizes medication management within the provider’s workflow. Bagging often introduces extra steps, like tracking shipments and matching drugs to appointments, increasing work for clinical staff.
Ultimately, each approach carries its own ripple effects for financial operations, patient experience, and practice management.
What is gold bagging, and how does it support patient care?
Gold bagging describes a model in which a health system’s own specialty pharmacy handles the entire spectrum of a patient’s medication journey. This includes everything from prescribing and dispensing to administering the medication—all managed internally, within the same health system.
By keeping each step “in house,” gold bagging allows for a high degree of coordination among the care team, pharmacy staff, and providers. As a result, patients often benefit from:
- Seamless communication among care providers
- Streamlined medication management and fewer communication delays
- Enhanced monitoring and support throughout treatment
- Holistic, patient-centered care within a single healthcare system
Health systems with robust specialty pharmacy programs can provide more personalized support, adapt quickly to patient needs, and close gaps in care—giving patients an experience that’s both more connected and more efficient.
